Welcome to our dedicated page for China Foods Hold SEC filings (Ticker: CFOO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on China Foods Hold's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into China Foods Hold's regulatory disclosures and financial reporting.
China Foods Holdings Ltd. reported a change in its external auditor. The company accepted the resignation of J & S Associate PLT as its independent registered public accounting firm, with the Board of Directors approving the change.
The prior auditor’s reports on the fiscal years ended December 31, 2025 and 2024 contained no adverse opinions, disclaimers, or qualifications, and the company states there were no disagreements or reportable events during those periods. China Foods Holdings engaged BZ CPA Inc. as its new independent registered public accounting firm effective March 20, 2026.
China Foods Holdings Ltd. (CFOO) filed its Q3 2025 report, showing higher sales but continued losses. Revenue rose to $96,828 in Q3 (from $22,403 a year ago) as healthcare product sales expanded. Nine‑month revenue increased to $239,083 (from $50,020).
Margins remained thin: Q3 gross profit was $8,870 (gross margin 9%) with operating expenses of $88,126, leading to a Q3 net loss of $79,246 (vs. $127,173). For the nine months, net loss was $280,153 (vs. $297,132), reflecting lower operating costs.
Liquidity is tight. Cash was $76,861 with net cash used in operations of $255,911 for the nine months, offset by $311,714 from director/related‑party financing. Customer deposits were $290,211. The company reported a stockholders’ deficit of $(1,148,732) and a working capital deficit of $(1,179,829) as of September 30, 2025. Management cites binding shareholder support and concluded there is no substantial doubt about going concern. Disclosure controls were deemed not effective. Shares outstanding were 20,252,309 as of November 10, 2025.